Supplementary Figure S5 from The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

Iseult M. Browne; Javier Pascual; Rosalind J. Cutts; Belinda Kingston; Sarah Hrebien; Lucy Suzanne Kilburn; Alex Pearson; Laura J. Moretti; Andrew M. Wardley; Iain R. Macpherson; Richard D. Baird; Rebecca Roylance; Miguel Gil‐Gil; Ángel L. Guerrero-Zotano; Isaac García-Murillas; Judith M. Bliss; Alistair E. Ring; Miguel Martín; Nicholas C. Turner

doi:10.1158/1078-0432.31006813

Supplementary Figure S5 from The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

2026 Open access

Read full text

Authors: Iseult M. Browne, Javier Pascual, Rosalind J. Cutts, Belinda Kingston, Sarah Hrebien, Lucy Suzanne Kilburn, Alex Pearson, Laura J. Moretti, Andrew M. Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance

+7 more

Miguel Gil‐Gil, Ángel L. Guerrero-Zotano, Isaac García-Murillas, Judith M. Bliss, Alistair E. Ring, Miguel Martín, Nicholas C. Turner

DOI: 10.1158/1078-0432.31006813

Cited by: 0

Abstract

Supplementary Figure 5: Boxplot graph showing distribution of CDR C2D1 values in patients in cohort E by BRCA status

Fields of Study & Subjects

BRCA gene mutations in cancer Cancer Genomics and Diagnostics Breast Cancer Treatment Studies

Publication details

Publication date: 6 January 2026